From our bioinformatics results, Pten/PI3K/AKT signaling and Nrf2 signaling may play key roles in the therapeutic mechanisms of Quercetagetin in RA, particularly concerning inflammatory osteolysis. This evidence concerns the gene PTEN and rheumatoid arthritis.